Archive | Pharmaceutical RSS feed for this section

Generics are real, and really impacting household and employer economies

Every 1 additional prescription per 100 that is filled with a generic Rx in the Rochester NY region yields $82 million in annual cost savings to the community: specifically, to employers, consumers and health plans. The Blue Cross Blue Shield Association presented findings from a survey and featured best practices from member plans in a [...]

Read full story Comments { 0 }

The cost of cancer: can you spell "u-n-d-e-r–i-n-s-u-r-a-n-c-e?"

Published a few months before her death, It’s Always Something is the autobiography from the great Gilda Radner, who died of ovarian cancer 20 years ago at the age of 42.    In the case of cancer, that “something” is all-too-often the case of under-insurance to cover treatment. High out-of-pocket costs for treatment, coupled with [...]

Read full story Comments { 0 }

Americans’ demand for generic drugs is up

4 in 5 Americans would choose generic drugs over brand name drugs, according to The Harris Poll conducted among American adults in December 2008. In Substantial Increase in Public Preference for Generic over Brand Name Drugs, Harris found that the proportion of people who would more often pick branded drugs fell by nearly one-half, from [...]

Read full story Comments { 0 }

Very slow growth forcast for pharma in U.S. in 2009

The U.S. pharmaceutical market is slow-growth for 2009, according to IMS Health. The company forecasts a tiny 1-2% growth rate for the next year. The data point comes from IMS’s annual Global Pharmaceutical and Therapy Forecast.   The U.S. market for pharmaceuticals will be worth about $300 bn in 2009.   What’s slowing growth prospects [...]

Read full story Comments { 0 }

Moving up the health care value chain: J&J in health services

Johnson & Johnson (J&J) has acquired the online health coaching company, HealthMedia. This will move the health supply company up the health care value chain further into the provision of health services. Nine years ago, I teamed with a Big Pharma on a scenario planning exercise about consumers and health care. One of our scenarios [...]

Read full story Comments { 0 }